Fosfomycin therapeutic drug monitoring in real-life: development and validation of a LC-MS/MS method on plasma samples-Reference-Cited by-同舟云学术

Fosfomycin therapeutic drug monitoring in real-life: development and validation of a LC-MS/MS method on plasma samples

Published:2021-08-19 Issue:1 Volume:34 Page:25-34
ISSN:1120-009X
Container-title:Journal of Chemotherapy
language:en
Short-container-title:Journal of Chemotherapy

Author:

Baldelli Sara¹,Cerea Matteo²,Mangioni Davide³⁴,Alagna Laura³,Muscatello Antonio³,Bandera Alessandra³⁵,Cattaneo Dario¹^ORCID

Affiliation:

1. Unit of Clinical Pharmacology, L. Sacco University Hospital, Milano, Italy

2. Department of Pharmaceutical Sciences, Università degli Studi di Milano, Milan, Italy

3. Infectious Diseases Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy

4. Department of Medical Biotechnology and Translational Medicine, Università di Milano, Milan, Italy

5. Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Milan, Italy

Publisher

Informa UK Limited

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology,Oncology

Link

https://www.tandfonline.com/doi/pdf/10.1080/1120009X.2021.1963617

Reference36 articles.

1. European Centre for Disease Prevention and Control. Antimicrobial resistance in EU/EEA (EARS-Net) – Annual Epidemiological Report 2019. Stockholm: ECDC; 2020.

2. Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015: a population-level modelling analysis

3. Fosfomycin

4. Fosfomycin: an old, new friend?

5. The revival of fosfomycin

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A quantitative method for the analysis of total and unbound concentrations of amoxicillin, ampicillin, ceftazidime, ceftriaxone, ertapenem, fosfomycin and penicillin G in human plasma with liquid chromatography–tandem mass spectrometry assay;Biomedical Chromatography;2024-08

2. Adverse events during intravenous fosfomycin therapy in a real-life scenario. Risk factors and the potential role of therapeutic drug monitoring;BMC Infectious Diseases;2024-06-28

3. A Sensitive Liquid Chromatography–Tandem Mass Spectrometry Method for Measuring Fosfomycin Concentrations in Human Prostatic Tissue;Pharmaceutics;2024-05-17

4. ICP-MS: a tool for detection and quantitation of fosfomycin residues in cleaning samples of finished product by estimation of phosphorous load;Journal of Analytical Atomic Spectrometry;2024